Trupti Nangare, MD
Family Practice · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 5
- 2 carriers
- Office
- 1
- Since medical school
- 23 years
- Graduated 2003
Offices
1 location · County of Santa Clara · 1,000 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
5 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Nangare’s office at (408) 885-5000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
5 of 5 plans
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A109815 · Current
Licensed to practise in California · since 2009 · expires 2027-09-30 · Maharashtra University of Health Sciences, Maharashtra Institute of Medical Education & Research.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Family Medicine - Family Medicine
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$697
Medicare paid this office $697 for 22 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Who their Medicare patients are
22 Original Medicare patients in 2024. Average age 69 · Health risk score 2.27. Sicker patients than 9 in 10 peers; the typical family practice clinician is at 1.13.
Conditions among them: High blood pressure 68%.
The office billed $12,799, Medicare allowed $1,087 and paid $697; for 29 services of 13 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 22 | 29 | 69 | 2.27 | $12,799 | $697 |
| 2023 | 20 | 26 | 77 | 1.02 | $12,225 | $894 |
| 2022 | 15 | 19 | 70 | 0.88 | $8,079 | $459 |
| 2021 | 18 | 30 | 70 | 1.94 | $14,148 | $1,051 |
| 2020 | 13 | 17 | 64 | 2.50 | $6,631 | $290 |
| 2019 | 15 | 15 | 67 | 1.50 | $9,427 | $684 |
| 2016 | 70 | 133 | 74 | 1.99 | $19,813 | $7,894 |
| 2015 | 39 | 76 | 76 | 2.12 | $11,597 | $4,638 |
| 2014 | 62 | 122 | 76 | 1.56 | $18,862 | $7,753 |
| 2013 | 44 | 56 | 67 | 1.46 | $8,869 | $2,242 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2016: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $6,849 | $56 |
2015: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,763 | $56 |
2014: 1 service
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 60 | $6,222 | $58 |
2013: 1 service
| Short return visit (20+ min) | 33 | $1,137 | $32 |
Medicaid work
$288,740 in 2024
Medicaid paid $288,740 for 5,137 billed services this clinician did in 2024, up to 86 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 544 | $280,746 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 13 | $6,138 |
| Short return visit (20+ min) | 1,081 | $1,323 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 12 | $185 |
| New patient visit (30+ min) | 40 | $149 |
| Return visit (30+ min) | 36 | $98 |
| Thyroid stimulating hormone (TSH) | 14 | $58 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 18 | $44 |
| Pain severity quantified; pain present (COA) (ONC) | 177 | $0 |
| Pain severity quantified; no pain present (COA) (ONC) | 218 | $0 |
| Medication list documented in medical record (COA) | 579 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 693 | $0 |
| 2024 | 5,137 | 21 | 86 | $288,740 |
| 2023 | 2,978 | 11 | 127 | $346,260 |
| 2022 | 2,901 | 12 | 93 | $348,870 |
| 2021 | 2,521 | 12 | 99 | $391,602 |
| 2020 | 2,101 | 5 | 95 | $245,739 |
| 2019 | 1,995 | 3 | 101 | $259,266 |
| 2018 | 1,586 | 5 | 112 | $246,440 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 692 | $342,829 |
| Short return visit (20+ min) | 1,353 | $3,405 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 12 | $20 |
| Urinalysis, by dip stick or tablet reagent for bilirubin, glucose, hemoglobin, ketones, leukocytes, nitrite, pH, protein, specific gravity, urobilinogen, any number of these constituents; automated, with microscopy | 12 | $6 |
| Infectious disease (viral respiratory tract infection), pathogen-specific RNA, 4 targets (severe acute respiratory syndrome coronavirus 2 [SARS-CoV-2], influenza A, influenza B, respiratory syncytial virus [RSV]), upper respiratory specimen, each pathogen reported as detected or not detected | 13 | $0 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 94 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 293 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 50 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 45 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 315 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 99 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 715 | $345,755 |
| Short return visit (20+ min) | 1,008 | $2,372 |
| Short return visit | 357 | $651 |
| Thyroid stimulating hormone (TSH) | 42 | $43 |
| Hemoglobin A1C level | 46 | $33 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 65 | $15 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 149 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 196 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 16 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 42 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 223 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 42 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 838 | $390,525 |
| Short return visit (20+ min) | 1,133 | $1,024 |
| Short return visit | 97 | $53 |
| Most recent hemoglobin A1c (HbA1c) level less than 7.0% (DM) | 59 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 130 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 19 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 23 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 139 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 16 | $0 |
| Most recent diastolic blood pressure greater than or equal to 90 mm Hg (HTN, CKD, CAD) (DM) | 18 | $0 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 24 | $0 |
| Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use | 25 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 762 | $243,365 |
| Short return visit (20+ min) | 747 | $1,307 |
| Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | 95 | $618 |
| Short return visit | 327 | $449 |
| Telephone evaluation and management service by a physician or other qualified health care professional who may report evaluation and management services provided to an established patient, parent, or guardian not originating from a related E/M service provided within the previous 7 days nor leading to an E/M service or procedure within the next 24 hours or soonest available appointment; 11-20 minutes of medical discussion | 170 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 826 | $256,669 |
| Short return visit (20+ min) | 1,073 | $2,598 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 96 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 789 | $244,345 |
| Short return visit (20+ min) | 645 | $1,700 |
| Return visit (30+ min) | 16 | $162 |
| Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | 105 | $160 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 31 | $74 |
Drugs they prescribed that Part D paid
$25,936
Pharmacies billed $25,936 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 3% of their Part D prescriptions (16 of 470) in 2024. Above the middle of the specialty; the typical family practice clinician is at 2%.
401 generic and fewer than 11 brand-name prescriptions · $25,936 in drug cost · 42 antibiotic prescriptions to 39 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Albuterol Sulfate Hfa | 20 | $711 | $36 |
| Gabapentin | 27 | $276 | $10 |
| Hydrocodone-Acetaminophen | 13 | $135 | $10 |
| Levothyroxine | 17 | $106 | $6 |
| Amlodipine Besylate | 28 | $96 | $3 |
See all 12 drugs
| Albuterol Sulfate Hfa | 20 | $711 | $36 |
| Gabapentin | 27 | $276 | $10 |
| Hydrocodone-Acetaminophen | 13 | $135 | $10 |
| Levothyroxine | 17 | $106 | $6 |
| Amlodipine Besylate | 28 | $96 | $3 |
| Losartan | 14 | $96 | $7 |
| Omeprazole | 14 | $56 | $4 |
| Baclofen | 11 | $52 | $5 |
| Ibuprofen | 12 | $51 | $4 |
| Azithromycin | 14 | $48 | $3 |
| Atorvastatin | 13 | $42 | $3 |
| Metformin | 13 | $34 | $3 |
Year by year
| 2024 | 470 | 185 | 3% (16) | None | $25,936 |
| 2023 | 490 | 196 | None | None | $16,225 |
| 2022 | 843 | 284 | 3% (22) | None | $53,229 |
| 2021 | 556 | 243 | 3% (15) | None | $63,206 |
| 2020 | 674 | 191 | 2% (11) | None | $41,920 |
| 2019 | 909 | 295 | 5% (45) | None | $31,316 |
| 2018 | 450 | 178 | 4% (17) | None | $20,385 |
| 2017 | 369 | 177 | 4% (14) | None | $14,316 |
| 2016 | 1,436 | 237 | 8% (107) | 15% | $84,039 |
| 2015 | 1,167 | 256 | 8% (88) | 18% | $63,549 |
| 2014 | 426 | 94 | 4% (15) | None | $20,190 |
| 2013 | 904 | 70 | 2% (19) | 17% | $36,149 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 14 drugs
| Albuterol Sulfate Hfa | 11 | $455 | $41 |
| Gabapentin | 25 | $395 | $16 |
| Fluticasone Propionate | 14 | $220 | $16 |
| Fosinopril | 15 | $163 | $11 |
| Omeprazole | 16 | $155 | $10 |
| Losartan | 16 | $155 | $10 |
| Amlodipine Besylate | 24 | $148 | $6 |
| Cephalexin | 16 | $139 | $9 |
| Metformin | 12 | $136 | $11 |
| Atorvastatin | 15 | $134 | $9 |
| Triamcinolone Acetonide | 12 | $115 | $10 |
| Levothyroxine | 16 | $107 | $7 |
| Baclofen | 12 | $90 | $7 |
| Ibuprofen | 23 | $88 | $4 |
2022: 20 drugs
| Albuterol Sulfate Hfa | 28 | $1,268 | $45 |
| Gabapentin | 55 | $962 | $17 |
| Levothyroxine | 35 | $499 | $14 |
| Omeprazole | 34 | $442 | $13 |
| Atorvastatin | 46 | $415 | $9 |
| Fosinopril | 19 | $350 | $18 |
| Pravastatin | 16 | $273 | $17 |
| Fluticasone Propionate | 27 | $247 | $9 |
| Metformin | 30 | $237 | $8 |
| Amlodipine Besylate | 45 | $205 | $5 |
| Atenolol | 19 | $162 | $9 |
| Triamcinolone Acetonide | 16 | $150 | $9 |
| Glipizide | 13 | $148 | $11 |
| Losartan | 16 | $147 | $9 |
| Simvastatin | 22 | $144 | $7 |
| Metoprolol | 12 | $115 | $10 |
| Baclofen | 14 | $113 | $8 |
| Alendronate | 17 | $107 | $6 |
| Hydrochlorothiazide | 17 | $60 | $4 |
| Ibuprofen | 14 | $50 | $4 |
2021: 11 drugs
| Albuterol Sulfate Hfa | 20 | $861 | $43 |
| Chlorthalidone | 11 | $378 | $34 |
| Levothyroxine | 19 | $376 | $20 |
| Gabapentin | 34 | $280 | $8 |
| Omeprazole | 21 | $260 | $12 |
| Atorvastatin | 20 | $218 | $11 |
| Amlodipine Besylate | 33 | $194 | $6 |
| Losartan | 19 | $172 | $9 |
| Metformin | 20 | $135 | $7 |
| Ibuprofen | 13 | $77 | $6 |
| Hydrochlorothiazide | 11 | $41 | $4 |
2020: 17 drugs
| Ventolin Hfa | 17 | $962 | $57 |
| Oseltamivir Phosphate | 16 | $858 | $54 |
| Diclofenac | 14 | $376 | $27 |
| Gabapentin | 37 | $371 | $10 |
| Levothyroxine | 17 | $367 | $22 |
| Baclofen | 17 | $256 | $15 |
| Fluticasone Propionate | 18 | $237 | $13 |
| Atorvastatin | 23 | $203 | $9 |
| Amlodipine Besylate | 35 | $161 | $5 |
| Hydrocortisone | 17 | $140 | $8 |
| Omeprazole | 17 | $127 | $7 |
| Ibuprofen | 25 | $105 | $4 |
| Metformin | 21 | $85 | $4 |
| Simvastatin | 14 | $80 | $6 |
| Cephalexin | 12 | $65 | $5 |
| Lisinopril | 12 | $52 | $4 |
| Metoprolol | 12 | $51 | $4 |
2019: 27 drugs
| Ventolin Hfa | 28 | $1,682 | $60 |
| Oseltamivir Phosphate | 16 | $1,160 | $73 |
| Proair Hfa | 14 | $614 | $44 |
| Gabapentin | 45 | $558 | $12 |
| Diclofenac | 16 | $389 | $24 |
| Omeprazole | 30 | $369 | $12 |
| Levothyroxine | 17 | $365 | $21 |
| Fluticasone Propionate | 22 | $275 | $12 |
| Ibuprofen | 60 | $219 | $4 |
| Atorvastatin | 14 | $176 | $13 |
| Amoxicillin-Clavulanate Potass | 18 | $165 | $9 |
| Amlodipine Besylate | 26 | $164 | $6 |
| Baclofen | 21 | $153 | $7 |
| Azithromycin | 22 | $142 | $6 |
| Triamcinolone Acetonide | 11 | $128 | $12 |
| Hydrocodone-Acetaminophen | 13 | $127 | $10 |
| Hydrocortisone | 18 | $109 | $6 |
| Acetaminophen-Codeine | 24 | $95 | $4 |
| Hydroxyzine | 12 | $88 | $7 |
| Losartan | 13 | $84 | $6 |
| Cephalexin | 13 | $74 | $6 |
| Metformin | 14 | $68 | $5 |
| Glipizide | 13 | $65 | $5 |
| Hydrochlorothiazide | 13 | $57 | $4 |
| Lisinopril | 13 | $56 | $4 |
| Alendronate | 12 | $51 | $4 |
| Prednisone | 14 | $31 | $2 |
2018: 11 drugs
| Ventolin Hfa | 32 | $1,649 | $52 |
| Oseltamivir Phosphate | 13 | $1,264 | $97 |
| Fluticasone Propionate | 17 | $179 | $11 |
| Gabapentin | 20 | $175 | $9 |
| Ibuprofen | 30 | $123 | $4 |
| Omeprazole | 15 | $98 | $7 |
| Azithromycin | 16 | $97 | $6 |
| Baclofen | 12 | $78 | $7 |
| Hydrocortisone | 11 | $73 | $7 |
| Atenolol | 11 | $60 | $5 |
| Prednisone | 11 | $45 | $4 |
2017: 5 drugs
| Ventolin Hfa | 20 | $1,065 | $53 |
| Azithromycin | 27 | $188 | $7 |
| Ibuprofen | 31 | $117 | $4 |
| Omeprazole | 14 | $111 | $8 |
| Ciprofloxacin | 13 | $66 | $5 |
2016: 37 drugs
| Advair Diskus | 24 | $10,002 | $417 |
| Januvia | 11 | $6,299 | $573 |
| Hydrocodone-Acetaminophen | 57 | $1,839 | $32 |
| Tamsulosin | 21 | $1,085 | $52 |
| Levothyroxine | 56 | $1,010 | $18 |
| Gabapentin | 73 | $889 | $12 |
| Proair Hfa | 16 | $862 | $54 |
| Ventolin Hfa | 15 | $784 | $52 |
| Omeprazole | 59 | $579 | $10 |
| Atorvastatin | 27 | $519 | $19 |
| Insulin | 17 | $461 | $27 |
| Amlodipine Besylate | 61 | $319 | $5 |
| Metformin | 50 | $299 | $6 |
| Triamcinolone Acetonide | 14 | $282 | $20 |
| Simvastatin | 49 | $277 | $6 |
| Fluoxetine | 20 | $266 | $13 |
| Fosinopril | 23 | $250 | $11 |
| Insulin | 13 | $235 | $18 |
| Glyburide | 17 | $221 | $13 |
| Glipizide | 22 | $211 | $10 |
| Losartan | 27 | $171 | $6 |
| Pantoprazole | 15 | $148 | $10 |
| Hydrochlorothiazide | 47 | $140 | $3 |
| Atenolol | 27 | $137 | $5 |
| Metoprolol | 19 | $135 | $7 |
| Ibuprofen | 26 | $124 | $5 |
| Fluticasone Propionate | 12 | $123 | $10 |
| Azithromycin | 19 | $114 | $6 |
| Naproxen | 14 | $101 | $7 |
| Benazepril | 12 | $89 | $7 |
| Alendronate | 15 | $87 | $6 |
| Finasteride | 11 | $86 | $8 |
| Trazodone | 11 | $75 | $7 |
| Furosemide | 11 | $53 | $5 |
| Tramadol | 15 | $47 | $3 |
| Citalopram Hbr | 13 | $30 | $2 |
| Clonazepam | 11 | $19 | $2 |
2015: 30 drugs
| Hydrocodone-Acetaminophen | 59 | $1,535 | $26 |
| Proair Hfa | 23 | $1,135 | $49 |
| Glyburide | 28 | $985 | $35 |
| Tamsulosin | 25 | $899 | $36 |
| Omeprazole | 48 | $789 | $16 |
| Gabapentin | 30 | $515 | $17 |
| Atorvastatin | 15 | $338 | $23 |
| Potassium Chloride | 12 | $308 | $26 |
| Insulin | 15 | $306 | $20 |
| Fosinopril | 19 | $303 | $16 |
| Doxazosin Mesylate | 12 | $271 | $23 |
| Amlodipine Besylate | 52 | $239 | $5 |
| Metformin | 36 | $225 | $6 |
| Fluticasone Propionate | 15 | $209 | $14 |
| Ibuprofen | 45 | $186 | $4 |
| Ondansetron | 14 | $185 | $13 |
| Levothyroxine | 13 | $178 | $14 |
| Simvastatin | 22 | $143 | $7 |
| Losartan | 20 | $143 | $7 |
| Pantoprazole | 15 | $134 | $9 |
| Metoprolol | 18 | $113 | $6 |
| Azithromycin | 17 | $99 | $6 |
| Naproxen | 15 | $97 | $6 |
| Hydrochlorothiazide | 26 | $96 | $4 |
| Ranitidine | 12 | $93 | $8 |
| Glipizide | 15 | $74 | $5 |
| Lisinopril | 11 | $70 | $6 |
| Prednisone | 14 | $53 | $4 |
| Atenolol | 13 | $52 | $4 |
| Furosemide | 24 | $46 | $2 |
2014: 11 drugs
| Gabapentin | 26 | $1,157 | $45 |
| Proair Hfa | 12 | $564 | $47 |
| Lovastatin | 19 | $320 | $17 |
| Lisinopril | 35 | $286 | $8 |
| Metformin | 19 | $249 | $13 |
| Levothyroxine | 13 | $203 | $16 |
| Omeprazole | 11 | $144 | $13 |
| Simvastatin | 12 | $124 | $10 |
| Glipizide | 12 | $99 | $8 |
| Hydrochlorothiazide | 29 | $97 | $3 |
| Trazodone | 12 | $50 | $4 |
2013: 25 drugs
| Lantus | 11 | $2,968 | $270 |
| Acarbose | 15 | $1,593 | $106 |
| Gabapentin | 31 | $1,076 | $35 |
| Lovastatin | 54 | $897 | $17 |
| Metformin | 63 | $829 | $13 |
| Proair Hfa | 17 | $801 | $47 |
| Lisinopril | 64 | $449 | $7 |
| Omeprazole | 23 | $441 | $19 |
| Glipizide | 43 | $422 | $10 |
| Levothyroxine | 42 | $417 | $10 |
| Diltiazem Er | 13 | $361 | $28 |
| Fluoxetine | 23 | $324 | $14 |
| Clopidogrel | 20 | $308 | $15 |
| Montelukast | 11 | $210 | $19 |
| Pravastatin | 12 | $183 | $15 |
| Amlodipine Besylate | 26 | $174 | $7 |
| Hydrochlorothiazide | 43 | $174 | $4 |
| Simvastatin | 15 | $168 | $11 |
| Furosemide | 36 | $159 | $4 |
| Atenolol | 30 | $131 | $4 |
| Levetiracetam | 12 | $129 | $11 |
| Ibuprofen | 24 | $118 | $5 |
| Enalapril Maleate | 14 | $109 | $8 |
| Metoprolol | 12 | $85 | $7 |
| Hydrocodone-Acetaminophen | 12 | $83 | $7 |
Professional record
- NPI
- 1679805089
- Licence
- CA A109815California A109815: Current · expires 2027-09-30
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Family medicine (207Q00000X)
- Mailing address
- 2710 Middlefield Rd, Redwood City, CA, 94063
- NPI first listed
- 2010-02-10
- NPI last updated
- 2013-07-11
This is when the NPI record was last certified, not a medical board exam.